Filing Details
- Accession Number:
- 0000711377-21-000017
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-04-27 14:26:38
- Reporting Period:
- 2021-04-23
- Accepted Time:
- 2021-04-27 14:26:38
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 711377 | Neogen Corp | NEOG | In Vitro & In Vivo Diagnostic Substances (2835) | 382367843 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1188987 | A Terri Morrical | No | No | No | Yes |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-04-23 | 1,121 | $62.70 | 38,696 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-04-26 | 1,121 | $96.97 | 37,575 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2021-04-26 | 800 | $62.70 | 38,375 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-04-26 | 800 | $97.09 | 37,575 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Common Stock (Right to Buy) | Disposition | 2021-04-23 | 1,121 | $0.00 | 1,121 | $62.70 |
| Common Stock | Common Stock (Right to Buy) | Disposition | 2021-04-26 | 800 | $0.00 | 800 | $62.70 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 88,879 | 2023-12-01 | No | 4 | M | Direct | |
| 88,079 | 2023-12-01 | No | 4 | M | Direct |
Footnotes
- Options were granted on 11/1/2018, have five year lives, and vest in equal annual 20% installments on each of the first five anniversary dates of the grant
Billionaire Hedge Funds
